Education
About Us
Working with TipRanks
Follow Us
Kenvue, Inc. (KVUE)
NYSE:KVUE
KVUE Stock Chart & Stats
$17.28
-$0.04(-0.19%)
At close: 4:00 PM EST
$17.28
-$0.04(-0.19%)
Day’s Range― - ―
52-Week Range$14.02 - $25.17
Previous CloseN/A
Volume2.33M
Average Volume (3M)38.42M
Market Cap
$33.05B
Enterprise Value$39.55B
Total Cash (Recent Filing)$1.14B
Total Debt (Recent Filing)$9.11B
Price to Earnings (P/E)23.2
Beta0.04
Next Earnings
Feb 05, 2026EPS Estimate
0.23Next Dividend Ex-DateN/A
Dividend Yield4.77%
Share Statistics
EPS (TTM)0.28
Shares Outstanding1,915,802,100
10 Day Avg. Volume37,462,264
30 Day Avg. Volume38,418,860
Financial Highlights & Ratios
PEG Ratio-0.98
Price to Book (P/B)4.20
Price to Sales (P/S)2.62
P/FCF Ratio30.38
Enterprise Value/Market Cap1.20
Enterprise Value/Revenue2.64
Enterprise Value/Gross Profit4.53
Enterprise Value/Ebitda13.44
Forecast
1Y Price Target
$19.42Price Target Upside12.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
AcquisitionKenvue agreed to be acquired by Kimberly-Clark in a cash and stock transaction.
Brand PortfolioKenvue's focus on a product portfolio of leading consumer healthcare brands, coupled with cost savings and demand generation investments, supports balanced growth.
ValuationThe acquisition values Kenvue at an enterprise value of $48.7 billion.
Bears Say
Legal RisksKenvue is in the news again due to concerns related to talc lawsuit liabilities in the UK, impacting the stock negatively.
Market PerformanceShares have moved down by nearly -30% since early-September due to Tylenol headlines and UK talc litigation.
Sales PerformanceSales of Tylenol have declined recently and there is a risk that negative headlines could push a broader set of consumers to shift to other pain relief options.
Kenvue, Inc. News
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $14.02 and its highest was $25.17 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Kenvue, Inc.’s market cap is $33.05B.
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is Feb 05, 2026 which is in 48 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on Sep 28, 2025. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.02.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Undervalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. pays a Quarterly dividend of $0.207 which represents an annual dividend yield of 4.77%. See more information on Kenvue, Inc. dividends here
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is 0.23.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,915,802,100 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $0.28 in its last earnings report, beating expectations of $0.26. Following the earnings report the stock price went up 2.203%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Currently, no hedge funds are holding shares in KVUE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kenvue, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$19.42 (12.38% Upside)
$19.42 (12.38% Upside)
Blogger Sentiment
Bullish
KVUE Sentiment 85%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 23.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $111.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 3.0%
Last 30 Days ▼ 3.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.34%
12-Months-Change
Fundamentals
Return on Equity
13.47%
Trailing 12-Months
Asset Growth
1.20%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue, Inc. (KVUE) is a leading consumer health company that specializes in providing a wide range of over-the-counter (OTC) products and health solutions. Operating in sectors such as personal care, wellness, and hygiene, Kenvue's core offerings include well-known brands in pain relief, skin and hair care, oral health, and baby care. The company focuses on delivering innovative and high-quality products that enhance consumer health and well-being.
KVUE Revenue Breakdown
42.23% Self Care
27.43% Skin Health and Beauty
30.33% Essential Health
KVUE Stock 12 Month Forecast
Average Price Target
$19.42
▲(12.38% Upside)
Technical Analysis
Ownership Overview
1.13% Insiders
30.77% Mutual Funds
21.81% Other Institutional Investors
17.19% Public Companies and Individual Investors